Ken Griffin's position in Intra-Cellular Therapies is currently worth $1.07 Million. That's 0.00% of their equity portfolio (2796th largest holding). The first Intra-Cellular Therapies trade was made in Q1 2015. Since then Ken Griffin bought shares 56 more times and sold shares on 48 occasions. The stake costed the investor $117 Thousand, netting the investor a gain of 809% so far.